Drug ID:   | NPD2621 |
Drug Name:   | |
Molecular Formula:   | C17H24FN3O6 |
Canonical SMILES:   | N=c1ccn(c(n1)O)[C@@H]1O[C@@H]([C@H]([C@@]1(C)F)OC(=O)C(C)C)OC(=O)C(C)C |
Standard InCHI:   | InChI=1S/C17H24FN3O6/c1-8(2)12(22)25-11-14(26-13(23)9(3)4)27-15(17(11,5)18)21-7-6-10(19)20-16(21)24/h6-9,11,14-15H,1-5H3,(H2,19,20,24)/t11-,14+,15-,17-/m1/s1 |
Standard InCHIKey:   | DPCPUBGYDXJDBP-HVDRQEDPSA-N |
Max Developmental Stage:   | Clinical (unspecified phase) |
Max Developmental Stage Source:   | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
Similarity Level | Similarity Score | Natural Product ID |
---|---|---|
Intermediate Similarity | 0.701 | NPC229249 |
Remote Similarity | 0.697 | NPC62927 |
Remote Similarity | 0.697 | NPC190334 |
Remote Similarity | 0.6574 | NPC328914 |
Remote Similarity | 0.6571 | NPC329384 |
Remote Similarity | 0.6569 | NPC328806 |
Remote Similarity | 0.6542 | NPC328779 |
Remote Similarity | 0.6509 | NPC6166 |
Remote Similarity | 0.6509 | NPC226769 |
Remote Similarity | 0.6509 | NPC280946 |
Remote Similarity | 0.6449 | NPC90240 |
Remote Similarity | 0.6449 | NPC120887 |
Remote Similarity | 0.6303 | NPC313813 |
Remote Similarity | 0.6154 | NPC318142 |
Remote Similarity | 0.602 | NPC469972 |
Remote Similarity | 0.5888 | NPC171116 |
Remote Similarity | 0.5794 | NPC245534 |
Remote Similarity | 0.5769 | NPC106780 |
Remote Similarity | 0.5755 | NPC89051 |
Remote Similarity | 0.5755 | NPC43246 |
Remote Similarity | 0.5703 | NPC471255 |
Remote Similarity | 0.5625 | NPC471262 |
Molecular Weight   | 385.16 |
ALogP   | 1.1347 |
MLogP   | 2.23 |
XLogP   | 2.814 |
HDA   | 9 |
HBD   | 2 |
Rotatable Bonds   | 14 |
TPSA   | 121.51 |
RO5 Violation   | 0 |